Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.
about
Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data.
P2860
Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@en
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@nl
type
label
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@en
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@nl
prefLabel
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@en
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@nl
P2093
P2860
P1433
P1476
Association of Adjuvant Tamoxi ...... n a General Community Setting.
@en
P2093
Amy Berrington de Gonzalez
Andrew G Glass
Estelle A Ntowe
Gretchen L Gierach
Robert N Hoover
Rochelle E Curtis
Ruth M Pfeiffer
Sarah J Nyante
P2860
P304
P356
10.1001/JAMAONCOL.2016.3340
P577
2016-10-06T00:00:00Z